The highs and lows of blood pressure: Toward meaningful clinical targets in patients with shock

Critical Care Medicine

Volumn 42, Issue 5, 2014, Pages 1241-1251

  Magder, Sheldon A ^a  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

arterial resistance; cardiac output; critical closing pressures; pressure flow relationships; shock; vasopressor therapy

Indexed keywords

NORADRENALIN;

ARTERIAL PRESSURE; BLOOD FLOW; BLOOD PRESSURE MEASUREMENT; CARDIOGENIC SHOCK; HEART OUTPUT; HEART STROKE VOLUME; HUMAN; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SYSTEMIC VASCULAR RESISTANCE; TISSUE PERFUSION;

BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; HUMANS; PRACTICE GUIDELINES AS TOPIC; REFERENCE VALUES; SHOCK; VASCULAR RESISTANCE; VASOCONSTRICTOR AGENTS;

EID: 84899488142     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000000324     Document Type: Review

References (52)

1. Lamontagne F, Cook DJ, Adhikari NK, et al: Vasopressor administration and sepsis: A survey of Canadian intensivists. J Crit Care 2011; 26:532.e1-532.e7
2. Dellinger RP, Levy MM, Rhodes A, et al; Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup: Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013; 41:580-637
3. Levy B, Collin S, Sennoun N, et al: Vascular hyporesponsiveness to vasopressors in septic shock: From bench to bedside. Intensive Care Med 2010; 36:2019-2029
4. Augusto JF, Teboul JL, Radermacher P, et al: Interpretation of blood pressure signal: Physiological bases, clinical relevance, and objectives during shock states. Intensive Care Med 2011; 37:411-419
5. Rosendorff C, Black HR, Cannon CP, et al; American Heart Association Council for High Blood Pressure Research; American Heart Association Council on Clinical Cardiology; American Heart Association Council on Epidemiology and Prevention: Treatment of hypertension in the prevention and management of ischemic heart disease: A scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention. Circulation 2007; 115:2761-2788
6. McGhee BH, Bridges EJ: Monitoring arterial blood pressure: What you may not know. Crit Care Nurse 2002; 22:60-64, 66
7. Shrier I: Critical Closing Pressures, Vascular Waterfalls, and the Control of Blood Flow to the Hindlimb. Montreal, Canada, Thesis for Faculty of Graduate Studies and Research McGill University, 1993
8. Azuma T, Oka S: Mechanical equilibrium of blood vessel walls. Am J Physiol 1971; 221:1310-1318
9. Burton AC: Total fluid energy, gravitational potential energy, effects of posture. In: Physiology and Biophysics of the Circulation: An Introductory Text. Chicago, IL, Year Book Medical Publishers Incorporated, 1965, pp 95-111
10. Bickley LS, Hoekelman RA (Eds): Bates Guide to Physical Examination and History Taking. Seventh Edition. Philadelphia, PA, Lippincott, 1999
11. Burton AC: Kinetic energy in the circulation. In: Physiology and Biophysics of the Circulation: An Introductory Text. Chicago, IL, Year Book Medical Publishers Incorporated, 1965, pp 102-112
12. Brengelmann GL: Counterpoint: The classical Guyton view that mean systemic pressure, right atrial pressure, and venous resistance govern venous return is not correct. J Appl Physiol (1985) 2006; 101:1525-1526
13. Magder S: Point: The classical Guyton view that mean systemic pressure, right atrial pressure, and venous resistance govern venous return is/is not correct. J Appl Physiol (1985) 2006; 101:1523-1525
14. Ross J Jr: Dynamics of the peripheral circulation. In: Best and Taylor's Physiological Basis of Medical Practice. West. J (Ed). Eleventh Edition. London/Baltimore, MD, Williams and Wilkins, 1985, pp 119-131
15. Magder S: Pressure-flow relations of diaphragm and vital organs with nitroprusside-induced vasodilatation. J Appl Physiol (1985) 1986; 61:409-416
16. Magder SA: The ups and downs of heart rate. Crit Care Med 2012; 40:239-245
17. Deschamps A, Magder S: Baroreflex control of regional capacitance and blood flow distribution with or without alpha-adrenergic blockade. Am J Physiol 1992; 263:H1755-H1763
18. Duling BR: Microvascular responses to alterations in oxygen tension. Circ Res 1972; 31:481-489
19. Berne RM: Regulation of coronary blood flow. Physiol Rev 1964; 44:1-29
20. Berne RM: Metabolic regulation of blood flow. Circ Res 1964; 15(Suppl):261-268
21. Guyton AC, Carrier O Jr, Walker JR: Evidence for tissue oxygen demand as the major factor causing autoregulation. Circ Res 1964; 15(Suppl):60-69
22. Mitchell JH, Shephard JT: Control of the circulation during exercise. In: Exercise-The Physiological Challenge. McNeil Hill P (Ed). Auckland, NZ, Conference Pub, 1993, pp 55-85
23. McCloskey DI, Mitchell JH: Reflex cardiovascular and respiratory responses originating in exercising muscle. J Physiol 1972; 224:173-186
24. Johnson PC: Autoregulation of blood flow. Circ Res 1986; 59:483-495
25. Standen NB, Quayle JM, Davies NW, et al: Hyperpolarizing vasodilators activate ATP-sensitive K+ channels in arterial smooth muscle. Science 1989; 245:177-180
26. Bayliss WM: On the local reactions of the arterial wall to changes of internal pressure. J Physiol 1902; 28:220-231
27. Johansson B, Mellander S: Static and dynamic components in the vascular myogenic response to passive changes in length as revealed by electrical and mechanical recordings from the rat portal vein. Circ Res 1975; 36:76-83
28. Dimmeler S, Assmus B, Hermann C, et al: Fluid shear stress stimulates phosphorylation of Akt in human endothelial cells: Involvement in suppression of apoptosis. Circ Res 1998; 83:334-341
29. García-Cardeña G, Fan R, Shah V, et al: Dynamic activation of endothelial nitric oxide synthase by Hsp90. Nature 1998; 392:821-824
30. Permutt S, Riley RL: Hemodynamics of collapsible vessels with tone: The vascular waterfall. J Appl Physiol 1963; 18:924-932
31. Magder S: Starling resistor versus compliance. Which explains the zero-flow pressure of a dynamic arterial pressure-flow relation? Circ Res 1990; 67:209-220
32. Sylvester JL, Traystman RJ, Permutt S: Effects of hypoxia on the closing pressure of the canine systemic arterial circulation. Circ Res 1981; 49:980-987
33. Shrier I, Hussain SNA, Magder SA: Carotid sinus stimulation influences both arterial resistance and critical closing pressure of the isolated hindlimb vascular bed. Am J Physiol 1993; 33:H1560-H1566
34. Shrier I, Magder S: Response of arterial resistance and critical pressure to changes in perfusion pressure in canine hindlimb. Am J Physiol 1993; 265:H1939-H1945
35. Shrier I, Baratz A, Magder S: Effects of adenosine on pressure-flow relationships in an in vitro model of compartment syndrome. J Appl Physiol 1997; 82:755-759
36. Shrier I, Magder S: NG-nitro-L-arginine and phenylephrine have similar effects on the vascular waterfall in the canine hindlimb. J Appl Physiol (1985) 1995; 78:478-482
37. Shrier I, Magder S: Effects of nifedipine on vascular waterfall and arterial resistance in canine hindlimb. Am J Physiol 1995; 268:H371-H376
38. Thiele RH, Nemergut EC, Lynch C 3rd: The clinical implications of isolated alpha(1) adrenergic stimulation. Anesth Analg 2011; 113:297-304
39. Magder S: Phenylephrine and tangible bias. Anesth Analg 2011; 113:211-213
40. Bersten AD, Hersch M, Cheung H, et al: The effect of various sympathomimetics on the regional circulations in hyperdynamic sepsis. Surgery 1992; 112:549-561
41. Gardner RM: Direct blood pressure measurement-dynamic response requirements. Anesthesiology 1981; 54:227-236
42. Bersten AD, Holt AW: Vasoactive drugs and the importance of renal perfusion pressure. New Horiz 1995; 3:650-661
43. Rudis MI, Basha MA, Zarowitz BJ: Is it time to reposition vasopressors and inotropes in sepsis? Crit Care Med 1996; 24:525-537
44. Datta P, Magder S: Hemodynamic response to norepinephrine with and without inhibition of nitric oxide synthase in porcine endotoxemia. Am J Respir Crit Care Med 1999; 160:1987-1993
45. Martin C, Viviand X, Leone M, et al: Effect of norepinephrine on the outcome of septic shock. Crit Care Med 2000; 28:2758-2765
46. Nasraway SA: Norepinephrine: No more "leave 'em dead"? Crit Care Med 2000; 28:3096-3098
47. Desjars P, Pinaud M, Bugnon D, et al: Norepinephrine therapy has no deleterious renal effects in human septic shock. Crit Care Med 1989; 17:426-429
48. Schaer GL, Fink MP, Parrillo JE: Norepinephrine alone versus norepinephrine plus low-dose dopamine: Enhanced renal blood flow with combination pressor therapy. Crit Care Med 1985; 13:492-496
49. Jansen TC, van Bommel J, Schoonderbeek FJ, et al; LACTATE study group: Early lactate-guided therapy in intensive care unit patients: A multicenter, open-label, randomized controlled trial. Am J Respir Crit Care Med 2010; 182:752-761
50. Jansen TC, van Bommel J, Woodward R, et al: Association between blood lactate levels, Sequential Organ Failure Assessment subscores, and 28-day mortality during early and late intensive care unit stay: A retrospective observational study. Crit Care Med 2009; 37:2369-2374
51. Rivers E, Nguyen B, Havstad S, et al; Early Goal-Directed Therapy Collaborative Group: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345:1368-1377
52. Magder S: Bench-to-bedside review: An approach to hemodynamic monitoring-Guyton at the bedside. Crit Care 2012; 16:236